- 8101. APEXCARDIOGRAM
- [ ] (UMLS (ICD9CM) C0199612) =Diagnostic Procedure
| - 8151. Apocrine Breast Carcinoma
- [An adenocarcinoma of the breast characterized by the presence of two intermingled cellular components: cells with abundant granular, eosinophilic cytoplasm, and cells with abundant cytoplasm containing fine empty vacuoles. ( NCI )] (UMLS (NCI) C1332316) Apocrine Carcinoma of Breast;
Apocrine Carcinoma of the Breast; Breast Apocrine Carcinoma =Neoplastic Process ; |
- 8102. Apha-((ethylamino)methyl)-3-hydroxybenzenemethanol
- [An adrenergic agonist with vasoconstrictive activity. Etilefrine selectively binds to and activates alpha-1-adrenergic receptors of the arteriolar and venous vasculature. This causes smooth muscle contraction and leads to a decrease in venous pooling and increase in blood pressure. This agent may also stimulate beta-1 adrenergic receptors, leading to positive chronotropic and inotropic effects. ( NCI )] (UMLS (NCI) C0015116) =Organic Chemical; Pharmacologic Substance ;
| - 8152. Apocrine Breast Carcinoma In Situ
- (UMLS (NCI) C1332315) Apocrine Carcinoma in situ of Breast;
Apocrine Carcinoma in situ of the Breast; Breast Apocrine Carcinoma in situ =Neoplastic Process ; |
- 8103. APHAKIA
- [Absence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION. ( MSH )] (UMLS (ICD9CM) C0003534) =Anatomical Abnormality ;
| - 8153. Apocrine Metaplasia
- (UMLS (NCI) C0334036) =Neoplastic Process
|
- 8104. Aphakia and other disorders of lens
- [ ] (UMLS (ICD9CM) C0155371) =Disease or Syndrome ;
| - 8154. Apocrine Metaplasia of Breast
- (UMLS (NCI) C0269252) =Disease or Syndrome
|
- 8105. aphasia
- [cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form; caused by diseases which affect the language areas of the dominant hemisphere; general categories include receptive, expressive, and mixed forms of aphasia. ( CSP )] (UMLS (CSP) C0003537) =Mental or Behavioral Dysfunction ;
| - 8155. Apocrine Neoplasm
- (UMLS (NCI) C1332318) Apocrine Neoplasm of Skin;
Apocrine Neoplasm of the Skin; Apocrine Skin Neoplasm; Apocrine Skin Tumor; Apocrine Tumor; Apocrine Tumor of Skin; Apocrine Tumor of the Skin =Neoplastic Process ; |
- 8106. Aphasia as late effect of cerebrovascular disease
- [ ] (UMLS (ICD9CM) C0489985) =Mental or Behavioral Dysfunction ;
| - 8156. Apocrine Sweat Gland
- (UMLS (NCI) C0930083) =Body Part, Organ, or Organ Component
|
- 8107. aphemia
- [ ] (UMLS (CSP) C0597893) =Mental or Behavioral Dysfunction
| - 8157. Apocrine Sweat Gland Hamartoma
- (UMLS (NCI) C1332319) Hamartoma of Apocrine Sweat Gland;
Hamartoma of the Apocrine Sweat Gland; =Disease or Syndrome ; |
- 8108. apheresis
- [(fer-E-sis) A procedure in which blood is collected, part of the blood such as platelets or white blood cells is taken out, and the rest of the blood is returned to the donor. ( NCI )] (UMLS (NCI) C0005791) =Therapeutic or Preventive Procedure ;
| - 8158. Apoda
- [ ] (UMLS (CSP) C0597830) =Amphibian
|
- 8109. aphidicolin
- [terpenoid compound from the fungus Cephalosporium amphidicola which inhibits eukaryotic, alpha-type DNA polymerases; used in tissue culture to synchronize cell division; derivatives are potential antineoplastic and antiAIDS agents. ( CSP )] (UMLS (CSP) C0085171) =Organic Chemical; Pharmacologic Substance =antimetabolite;
| - 8159. apoenzyme
- [protein components of the enzyme minus any cofactors or prosthetic groups that might be required for the enzyme to be catalytically functional. ( CSP )] (UMLS (CSP) C0003589) =Amino Acid, Peptide, or Protein; Enzyme
|
- 8110. APHONIA
- [Complete loss of phonation due to organic disease of the larynx or to nonorganic (i.e., psychogenic) causes. ( MSH )] (UMLS (ICD9CM) C0003564) =Sign or Symptom ;
| - 8160. apolipoprotein
- [protein components of lipoproteins which remain after the lipids to which the proteins are bound have been removed; they play an important role in lipid transport and metabolism. ( CSP )] (UMLS (CSP) C0003591) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 8111. aphthous stomatitis
- [recurrent disease of the oral mucosa of unknown etiology, characterized by small white ulcerative lesions lasting 7 to 14 days. ( CSP )] (UMLS (CSP) C0038363) =Disease or Syndrome ;
=skin ulcer; stomatitis | - 8161. apolipoprotein J
- [a widely distributed glycoprotein with a diverse set of biologic actions, the most prominent of which is its ability to promote cell interactions; another unique feature is its induction at times of tissue injury and remodeling. ( CSP )] (UMLS (CSP) C0055966) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=apolipoprotein; glycoprotein |
- 8112. Aphthovirus
- [A genus of the family PICORNAVIRIDAE infecting mainly cloven-hoofed animals. They cause vesicular lesions and upper respiratory tract infections. FOOT AND MOUTH DISEASE VIRUS is the type species. ( MSH )] (UMLS (CSP) C0016515) =Virus ;
| - 8162. Apolizumab/Rituximab
- (UMLS (NCI) C1134497) =Therapeutic or Preventive Procedure
|
- 8113. API 20 Strep
- [Identification, API 20 Strep ( HL7V3.0 )] (UMLS (HL7) C1553129) =Laboratory Procedure =ObservationMethod;
| - 8163. Apollon
- [Baculoviral IAP Repeat-Containing Protein 6, encoded by the BIRC6 gene, is a member of the IAP (inhibitors of apoptosis proteins) family and the ubiquitin-conjugating enzyme family. This protein is expressed as a 530-kD protein in gliomas and ovarian cancers. BIRC6 may protect cancer cells from undergoing apoptosis and resist to apoptosis in the presence of anticancer drugs. BIRC6 contains a 70-amino acid cysteine- and histidine-rich baculovirus IAP repeat (BIR) and a zinc-binding RING finger. ( NCI )] (UMLS (NCI) C0910612) Baculoviral IAP Repeat-Containing Protein 6;
BIRC6; KIAA1289; =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 8114. API 20A
- [Identification, API 20A ( HL7V3.0 )] (UMLS (HL7) C1553130) =Laboratory Procedure =ObservationMethod;
| - 8164. Apomine
- (UMLS (NCI) C0919349) =Organic Chemical; Pharmacologic Substance ;
|
- 8115. API 20C AUX
- [Identification, API 20C AUX ( HL7V3.0 )] (UMLS (HL7) C1553131) =Laboratory Procedure =ObservationMethod;
| - 8165. apomorphine
- [derivative of morphine that is a dopamine D2 agonist; a powerful emetic useful in acute poisoning; has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. ( CSP )] (UMLS (CSP) C0003596) =Organic Chemical; Pharmacologic Substance
|
- 8116. API 20E
- [Identification, API 20E ( HL7V3.0 )] (UMLS (HL7) C1553132) =Laboratory Procedure =ObservationMethod;
| - 8166. Aponeurosis
- (UMLS (NCI) C0225205) =Tissue
|
- 8117. API 20NE
- [Identification, API 20NE ( HL7V3.0 )] (UMLS (HL7) C1553133) =Laboratory Procedure =ObservationMethod;
| - 8167. Apopain
- [Caspase-3, encoded by the CASP3 gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. Caspase-3 is a central player in mediating apoptosis and is the most widely studied caspase. This protein cleaves and activates caspases 6, 7 and 9, and itself can be processed by caspases 8, 9 and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. Alternative splicing of the CASP3 gene results in two transcript variants which encode the same protein. (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C0291573) =Amino Acid, Peptide, or Protein; Enzyme
|
- 8118. API 50 CH
- [Identification, API 50 CH ( HL7V3.0 )] (UMLS (HL7) C1553134) =Laboratory Procedure =ObservationMethod;
| - 8168. apophysis ossium
- [ ] (UMLS (CSP) C0872099) =Body Part, Organ, or Organ Component ;
|
- 8119. API An-IDENT
- [Identification, API An-IDENT ( HL7V3.0 )] (UMLS (HL7) C1553135) =Laboratory Procedure =ObservationMethod;
| - 8169. apoplipoprotein AI
- [ ] (UMLS (CSP) C0872100) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 8120. API Coryne
- [Identification, API Coryne ( HL7V3.0 )] (UMLS (HL7) C1553136) =Laboratory Procedure =ObservationMethod;
| - 8170. apoptosis
- [(ap-o-TOE-sis) A normal series of events in a cell that leads to its death. ( NCI )] (UMLS (NCI) C0162638) =Cell Function ;
=cell death; Cellular Biology |
- 8121. API Rapid 20E
- [Identification, API Rapid 20E ( HL7V3.0 )] (UMLS (HL7) C1553137) =Laboratory Procedure =ObservationMethod;
| - 8171. Apoptosis Antigen Ligand 1
- [FAS ligand is a TNF family, type II transmembrane protein expressed on many cell types and secreted from T-cells upon TCR ligation by MHC/peptide complexes residing on antigen presenting cells. FAS ligand triggers cell death by binding to the cell surface receptor FAS, another transmembrane protein member of the TNF receptor family. FAS ligand is expressed in activated splenocytes and thymocytes, consistent with its involvement in T-cell-mediated cytotoxicity, and in the liver, lung, ovary, and heart, where its function is unclear. (from OMIM 134638 and NCI) ( NCI )] (UMLS (NCI) C0253023) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 8122. API Staph
- [Identification, API Staph ( HL7V3.0 )] (UMLS (HL7) C1553138) =Laboratory Procedure =ObservationMethod;
| - 8172. Apoptosis Inducing Protein TRICK2A/2B
- [Receptor for Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) ( NCI )] (UMLS (NCI) C0664123) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 8123. API ZYM
- [Identification, API ZYM ( HL7V3.0 )] (UMLS (HL7) C1553139) =Laboratory Procedure =ObservationMethod;
| - 8173. Apoptosis Induction
- [Mechanisms involved in Induction of Apoptosis initiate biochemical processes, often enzymatic cascades, that promote programmed cell death. ( NCI )] (UMLS (NCI) C1326205) Induction of Apoptosis;
=Cell Function |
- 8124. API1
- [This gene is a potent inhibitor of apoptosis and plays an important role in apoptotic signal transduction. ( NCI )] (UMLS (NCI) C1332414) Baculoviral IAP Repeat-Containing 2 Gene;
BIRC2; BIRC2 Gene =Gene or Genome ; | - 8174. Apoptosis Inhibitor
- [Encoded by Apoptosis Inhibitor Genes, Apoptosis Inhibitor proteins impede the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332320) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 8125. API4
- [an anti-apoptosis protein expressed in lymphoma and cancers of lung, colon, pancreas, prostate and breast; potent inhibitor of some caspases. ( CSP )] (UMLS (NCI) C0664336) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=MAP; Tumor Antigen | - 8175. Apoptosis Inhibitor 2
- [Encoded by BIRC3 Gene (IAP Family) Baculoviral IAP Repeat-Containing Protein 3 inhibits apoptosis by binding to TNF Receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation of ICE-like proteases. BIRC3 inhibits apoptosis induced by serum deprivation but does not affect apoptosis resulting from exposure to menadione, a potent inducer of free radicals. The amino acid sequence predicts three baculovirus IAP repeat domains and a ring-type zinc finger domain while the Zn binding domain is involved in protein-protein interactions in caspase inhibition and spindle assembly. BIRC3 is present in many fetal and adult tissues and mainly expressed in adult skeletal muscle, thymus, testis, ovary, and pancreas, low or absent in brain and peripheral blood leukocytes. ( NCI )] (UMLS (NCI) C0763658) Baculoviral IAP Repeat-Containing Protein 3;
BIRC3; Cellular Inhibitor of Apoptosis-2; Human Inhibitor of Apoptosis Protein-1; Mammalian IAP Homolog C; =Amino Acid, Peptide, or Protein; Biologically Active Substance ; |
- 8126. Apical
- [Relating to or located at the tip (an apex). ( NCI )] (UMLS (NCI) C0205111) =Spatial Concept
| - 8176. Apoptosis Inhibitor 3
- [Encoded BIRC4 Gene (IAP Family), Baculoviral IAP Repeat-Containing Protein 4 inhibits apoptosis through binding to TNF Receptor-associated factors TRAF1 and TRAF2. Similar to BIRC2, BIRC4 inhibits apoptosis induced by menadione, a potent inducer of free radicals, and ICE. BIRC4 also specifically inhibits cell-death proteases, caspase-3 and caspase-7. A novel transcript homologous to BIRC4 is expressed solely in the testis. ( NCI )] (UMLS (NCI) C1173600) Baculoviral IAP Repeat-Containing Protein 4;
BIRC4; IAP-Like Protein; X-linked Inhibitor of Apoptosis =Amino Acid, Peptide, or Protein; Biologically Active Substance ; |
- 8127. apical membrane
- [cell membrane found on the surface of vertebrate epithelial cells which faces the external lumen and may be involved in transport of substances across the cell. ( CSP )] (UMLS (CSP) C0596119) =Cell Component ;
=cell membrane; | - 8177. Apoptosis Inhibitor Gene
- [Apoptosis Inhibitor Genes encode Apoptosis Inhibitor proteins, which impede the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332321) =Gene or Genome ;
|
- 8128. Apical Myocardial Infarction
- (UMLS (NCI) C1168331) =Disease or Syndrome
| - 8178. Apoptosis Promoter
- [Encoded by Apoptosis Promoter Genes, Apoptosis Promoter proteins promote the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332322) Inducer of Apoptosis =Amino Acid, Peptide, or Protein ;
|
- 8129. Apicectomy
- [The surgery involving excision of the apex of the petrous portion of the temporal bone. ( NCI )] (UMLS (NCI) C0003571) =Therapeutic or Preventive Procedure ;
| - 8179. Apoptosis Promoter Gene
- [Apoptosis Promoter Genes encode Apoptosis Promoter proteins, which promote the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332323) =Gene or Genome ;
|
- 8130. Apicoectomy and root canal therapy
- [ ] (UMLS (ICD9CM) C0176403) =Therapeutic or Preventive Procedure
| - 8180. Apoptosis Regulation Gene
- [Apoptosis Regulation Genes encode Apoptosis Regulator proteins, which either promote or impede the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332324) =Gene or Genome ;
|
- 8131. Apicomplexa
- [phylum of protozoa characterized by the presence of complex apical organelles generally consisting of a conoid that aids in penetrating host cells, rhoptries that possibly secrete a proteolytic enzyme, and subpellicular microtubules that may be related to motility. ( CSP )] (UMLS (CSP) C0085316) =Invertebrate ;
=protozoa; =Babesia; Coccidia; Plasmodium; | - 8181. Apoptosis Regulator
- [Encoded by Apoptosis Regulation Genes, Apoptosis Regulator proteins either promote or impede the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332325) Regulator of Apoptosis =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 8132. APL unit
- [biologic activity of anticardiolipin IgA ( HL7V3.0 )] (UMLS (HL7) C1552996) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 8182. Apoptosis Regulator BAK
- [A BCL2 related protein that induces apoptosis. May cause the mitochondrial voltage-dependent anion channel to open and release cytochrome c into the cytoplasm resulting in caspase activation. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C0296517) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 8133. Aplastic anemia and other bone marrow failure syndromes
- [ ] (UMLS (ICD9CM) C1719323) =Disease or Syndrome
| - 8183. Apoptosis Regulator BCL-W
- [This protein is a member of the BCL-2 protein family. Expression of this protein in cells has been shown to contribute to reduced cell apoptosis under cytotoxic conditions. Studies of the related gene in mice indicated a role in the survival of NGF- and BDNF-dependent neurons. Mutation and knockout studies of the mouse gene demonstrated an essential role in adult spermatogenesis. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C1332395) BCL2 Like 2;
BCL2L2; BCL2L2 Protein; BCL2-Like 2; BCL2-Related 2 Protein; BCLW; BCL-W; KIAA0271; =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 8134. Aplastic Anemia due to Infection
- (UMLS (NCI) C0271912) =Disease or Syndrome
| - 8184. Apoptosis Response Protein
- [Apoptosis Response Protein, encoded by the PAWR gene, is a WT1-interacting protein that itself functions as a transcriptional repressor. It contains a putative leucine zipper domain which interacts with the zinc finger DNA binding domain of WT1. Apoptosis Response Protein is specifically upregulated during apoptosis of prostate cells. (from LocusLink) ( NCI )] (UMLS (NCI) C0529535) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 8135. Aplastic Anemia due to Radiation
- (UMLS (NCI) C0472734) =Disease or Syndrome
| - 8185. Apoptosis-Inducing NBK
- [This protein is known to interact with cellular and viral survival-promoting proteins, such as BCL2, BCLXL, Epstein-Barr virus BHRF1, and adenovirus E1B 19-kD in order to enhance programed cell death. Because its activity is suppressed in the presence of survival-promoting proteins, this protein is suggested as a likely target for antiapoptotic proteins. This protein shares a critical BH3 domain with other death-promoting proteins, BAX and BAK. (from RefSeq Summary and OMIM) ( NCI )] (UMLS (NCI) C1332394) BCL2-Interacting Killer;
BIK; =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 8136. APLASTIC ANEMIAS NEC
- [ ] (UMLS (ICD9CM) C1955746) Other specified aplastic anemias;
=Disease or Syndrome | - 8186. Apoptotic Cysteine Protease MCH2
- [Caspase-6, encoded by the CASP6 Gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. Caspase-6 can be processed by caspases 7, 8 and 10, and functions as a downstream enzyme in the activation cascade of caspases responsible for apoptosis execution. It cleaves poly(ADP-ribose) polymerase in vitro, as well as lamins. Alternative splicing of this gene results in two transcript variants which encode different isoforms. Its overexpression promotes programmed cell death. (From LocusLink, Swiss-Prot and NCI) ( NCI )] (UMLS (NCI) C0538091) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 8137. APLD
- [An anticancer drug obtained from a marine animal. ( NCI )] (UMLS (NCI) C0388638) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 8187. Apoptotic Protease Mch-3
- [Caspase-7, encoded by the CASP7 Gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. The precursor of this caspase can be cleaved by caspase 3 and 10. It has been shown to be activated upon cell death stimuli and induce apoptosis. Alternative splicing of this gene results in 4 transcript variants, which encode 3 distinct isoforms. (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C0537969) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 8138. Aplysia
- [genus of motile gastropods with a poorly developed or missing shell; used in neurobiology studies because it possesses a simple nervous system with large, individually identifiable neurons. ( CSP )] (UMLS (CSP) C0003577) =Invertebrate ;
| - 8188. aporphine
- [Dibenzoquinolines derived in plants from (S)-reticuline (BENZYLISOQUINOLINES). ( MSH )] (UMLS (CSP) C0003606) =Organic Chemical ;
|
- 8139. Aplysia Ras-Related Homolog 12
- [RHO A GTP-binding protein is involved in regulating signal transduction pathways that control assembly of focal adhesions and actin stress fibers. Rho regulates remodeling of the actin cytoskeleton during cell morphogenesis and motility. Active Rho signals to its downstream effector ROCK1, which phosphorylates and activates LIM kinase. LIM kinase, in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. (from OMIM 165390 and NCI) ( NCI )] (UMLS (NCI) C0084340) =Amino Acid, Peptide, or Protein; Enzyme
| - 8189. APP ADHESION BARRIER SUB
- (UMLS (ICD9CM) C1135463) Application or administration of adhesion barrier substance =Therapeutic or Preventive Procedure
|
- 8140. Aplysia RAS-Related Homolog 9
- [RHO C protein is a product of the ARHC gene that regulates remodeling of the actin cytoskeleton during cell morphogenesis and motility. Rho C enhances metastasis when over expressed, whereas a dominant-negative Rho inhibits metastasis. Analysis of the phenotype of cells expressing dominant-negative Rho C indicates that Rho C is important in tumor cell invasion. (from OMIM 165380 and NCI) ( NCI )] (UMLS (NCI) C0084342) =Amino Acid, Peptide, or Protein; Enzyme
| - 8190. APP EXT FIX DEV-MONOPLAN
- [ ] (UMLS (ICD9CM) C1561937) Application of external fixator device, monoplanar system;
=Therapeutic or Preventive Procedure |
- 8141. apnea
- [cessation of breathing. ( CSP )] (UMLS (CSP) C0003578) =Pathologic Function ;
| - 8191. APP EXT FIX DEV-RING SYS
- [ ] (UMLS (ICD9CM) C1561938) Application of external fixator device, ring system;
=Therapeutic or Preventive Procedure |
- 8142. apneustic center
- [ ] (UMLS (CSP) C1536992) =Body Location or Region
| - 8192. APP HYBRID EXT FIX DEV
- [ ] (UMLS (ICD9CM) C1561941) Application of hybrid external fixator device;
=Therapeutic or Preventive Procedure |
- 8143. APO
- (UMLS (NCI) C0285452) =Therapeutic or Preventive Procedure ;
| - 8193. Appeal Reason
- (UMLS (HL7) C1547740) =Idea or Concept =HL7 Vocabulary Version 2.5;
|
- 8144. Apo B
- [structural proteins of chylomicrons, VLDL, and LDL; important in secretion and transport of lipoproteins; binding proteins for LDL receptor pathway. ( CSP )] (UMLS (CSP) C0003593) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 8194. Appearance
- (UMLS (HL7) C1547010) =Quantitative Concept =Kind of quantity;
|
- 8145. Apo E
- [prominent protein constituents of plasma VLDL, chylomicrons, and a subfraction of HDL as well as of remnant lipoproteins which are derived from the lipoprotein lipase-mediated intravascular catabolism of triglyceride-rich lipoproteins; recognized by the LDL receptor and Apo E receptor; any defect in the Apo E metabolism leads to increased plasma Apo E levels; a strong association has been found between high levels of Apo E and type III hyperlipoproteinemia. ( CSP )] (UMLS (CSP) C0003595) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 8195. Appearance
- [The outward or visible aspect of a person or thing. ( NCI )] (UMLS (NCI) C0700364) =Qualitative Concept
|
- 8146. APO-1 Cell Surface Antigen
- [differentiation antigens expressed on a variety of cell lines; regulate peripheral immune responses. ( CSP )] (UMLS (NCI) C0245662) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor =CD antigen;
| - 8196. appendage
- [A natural prolongation or projection from a part of an organism either animal or plant; a part that is joined to something larger. ( NCI )] (UMLS (CSP) C0598782) =Body Part, Organ, or Organ Component ;
|
- 8147. APO1 antigen
- [ ] (UMLS (CSP) C0599661) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 8197. Appendage of the Uterus
- [The fallopian tubes, ovaries, and supporting ligaments of the uterus. (MeSH) ( NCI )] (UMLS (NCI) C0001575) =Body Part, Organ, or Organ Component ;
|
- 8148. APO2 Ligand
- [Tumor Necrosis Factor Ligand Superfamily Member 10, encoded by the TNFSF10 Gene, is a homotrimeric type II membrane protein that rapidly induces oligomerization of receptor intracellular death domains and apoptosis in a variety of cells. It preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. This protein binds to several members of TNF receptor superfamily including TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and possibly also to TNFRSF11B/OPG. The activity of this protein may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and TNFRSF11B/OPG that cannot induce apoptosis. The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3. (From LocusLink, OMIM and NCI) ( NCI )] (UMLS (NCI) C0385242) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 8198. Appendectomy
- [Surgical removal of the vermiform appendix. ( NCI )] (UMLS (ICD9CM) C0003611) =Therapeutic or Preventive Procedure
|
- 8149. Apocrine Adenoma
- [A benign epithelial neoplasm arising from the apocrine sweat glands. Representative examples include tubular apocrine adenoma and external auditory canal ceruminous adenoma. ( NCI )] (UMLS (NCI) C0334345) =Neoplastic Process
| - 8199. Appendiceal Carcinoid Neoplasm
- [A well differentiated neuroendocrine neoplasm arising from the wall of the appendix. It is characterized by the presence of neoplastic cells forming round solid nests and occasionally glandular structures. The majority of the cases are asymptomatic, and they are found incidentally in appendectomy specimens. The majority of the tumors are located in the distal end of the appendix and they are enterochromaffin-cell carcinoid tumors producing serotonin. Most cases show morphologic evidence of appendiceal wall and lymphatic vessel invasion by tumor cells. Despite the morphologic evidence of invasion, appendiceal carcinoid tumors only infrequently produce lymph node or distant metastases. ( NCI )] (UMLS (NCI) C0334298) =Neoplastic Process
|
- 8150. Apocrine Adenosis of Breast
- (UMLS (NCI) C1332314) Apocrine Adenosis of the Breast;
Breast Apocrine Adenosis; =Disease or Syndrome ; | - 8200. Appendiceal Colloid Cystadenocarcinoma
- [An adenocarcinoma arising from the appendix, characterized by the presence of mucinous stroma formation and cystic structures. ( NCI )] (UMLS (NCI) C1096639) Appendiceal Colloidal Cystadenocarcinoma;
Appendiceal Mucinous Cystadenocarcinoma; Appendix Colloid Cystadenocarcinoma; Appendix Colloidal Cystadenocarcinoma; Appendix Mucinous Cystadenocarcinoma; Colloid Cystadenocarcinoma of Appendix; Colloid Cystadenocarcinoma of the Appendix; Colloidal Cystadenocarcinoma of Appendix; Colloidal Cystadenocarcinoma of the Appendix; Mucinous Cystadenocarcinoma of Appendix; Mucinous Cystadenocarcinoma of the Appendix =Neoplastic Process ; |